Brief: Personalis Announces New Data From Neoadjuvant Lung Cancer Trial
03/09/2025 22:46
Sept 3 (Reuters) - Personalis Inc PSNL.O: PERSONALIS ANNOUNCES NEW DATA FROM A LANDMARK NEOADJUVANT LUNG CANCER TRIAL SHOWING SUPERIORITY OF ULTRA-SENSITIVE, TUMOR-INFORMED MRD TESTING Source text: ID:nBw2vMthDa Further company coverage: PSNL.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Personalis
See all newsBrief: Personalis - Announces Commercial Launch Of Real-Time Variant Tracker In Next Personal Mrd Test
U.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
Personalis slips as BTIG downgrades, sees no rival bid for Tempus deal
Brief: Personalis Receives New Task Order Under U.S. Veterans Affairs Contract For VA MVP
Personalis, Inc. reports results for the quarter ended June 30 - Earnings Summary